Sources

[←1]

^{Li, Xinguang, Norbert E. Kaminski, and Lawrence J. Fischer. “Examination of the immunosuppressive effect of Δ 9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.” International immunopharmacology 1.4 (2001): 699-712.}

[←2]

^{Weiss, L., et al. “Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.” Autoimmunity 39.2 (2006): 143-151.}

[←3]

^{Weiss, Lola, et al. “Cannabidiol arrests onset of autoimmune diabetes in NOD mice.” Neuropharmacology 54.1 (2008): 244-249.}

[←4]

^{Rajesh, Mohanraj, et al. “Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.” Journal of the American College of Cardiology 56.25 (2010): 2115-2125.}

[←5]

^{Alshaarawy, Omayma, and James C. Anthony. “Cannabis Smoking and Diabetes Mellitus.” Epidemiology 26.4 (2015): 597-600.}

[←6]

^{Penner, Elizabeth A., Hannah Buettner, and Murray A. Mittleman. “The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.” The American journal of medicine 126.7 (2013): 583-589.}

[←7]

^{Rajavashisth, Tripathi B., et al. “Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.” BMJ open 2.1 (2012): e000494.}

[←8]

^{Wargent, E. T., et al. “The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.” Nutrition & diabetes 3.5 (2013): e68.}

[←9]

^{El-Remessy, Azza B., et al. “Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.” The American journal of pathology 168.1 (2006): 235-244.}

[←10]

^{El-Remessy, A. B., et al. “Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes.” Molecular vision 16 (2010): 1487.}

[←11]

^{Toth, Cory C., et al. “Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.” Molecular pain 6.1 (2010): 16.}

[←12]

^{Rajesh, Mohanraj, et al. “Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.” American Journal of Physiology-Heart and Circulatory Physiology 293.1 (2007): H610-H619.}